Dissecting gastric cancer biology and how and when to use immunotherapy
Das Thakur, M., Okrah, K., Shames, D., Hegde, P., Bais, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1O Clinical outcomes in post-operative ctDNA-positive muscle-invasive urothelial carcinoma (MIUC) patients after atezolizumab adjuvant therapy
Powles, T.B., Assaf, Z.J., Davarpanah, N., Hussain, M., Oudard, S., Gschwend, J.E., Albers, P., Castellano, D., Nishiyama, H., Daneshmand, S., Grivas, P., Sharma, S., Sethi, H., Aleshin, A., Zhang, J., Degaonkar, V., Bais, C., Carter, C.A., Bellmunt, J., Mariathasan, S.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Identification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B
Das Thakur, M., Udyavar, A., Sandmann, T., Li, C., Bosch, L.J.W., O’Gorman, W., Li, Y., Au-Yeung, A., Takahashi, C., Bourgon, R., Daemen, A., Hegde, P., Bais, C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The Kaposi's Sarcoma-associated Herpes Virus G Protein-coupled Receptor Up-Regulates Vascular Endothelial Growth Factor Expression and Secretion through Mitogen-activated Protein Kinase and p38 Pathways Acting on Hypoxia-inducible Factor 1 alpha
Sodhi, A, Montaner, S, Patel, V, Zohar, M, Bais, C, Mesri, E A, Gutkind, J S
Published in Cancer research (Chicago, Ill.) (01.09.2000)
Get full text
Published in Cancer research (Chicago, Ill.) (01.09.2000)
Journal Article
1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)
Miles, D, Cameron, D, Bondarenko, I, Lyudmila, M, Alcedo, J.C, Lopez, R.I, Im, S.A, Canon, J.L, Shparyk, Y, Yardley, D, Masuda, N, Ro, J, Hubeaux, S, Quah, C, Bais, C, O'Shaughnessy, J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1875PD - Targeting molecular mediators of T cell exclusion for effective immunotherapy in ovarian cancer
Wang, Y., Desbois, M., Udyavar, A., Ryner, L., Kozlowski, C., Guan, Y., Dürrbaum, M., Lu, S., Fortin, J.-P., Koeppen, H., Ziai, J., Chang, C.-W., Lo, A., Keerthivasan, S., Plante, M., Bais, C., Hegde, P., Daemen, A., Turley, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Targeting molecular mediators of T cell exclusion for effective immunotherapy in ovarian cancer
Wang, Y., Desbois, M., Udyavar, A., Ryner, L., Kozlowski, C., Guan, Y., Dürrbaum, M., Lu, S., Fortin, J.-P., Koeppen, H., Ziai, J., Chang, C.-W., Lo, A., Keerthivasan, S., Plante, M., Bais, C., Hegde, P., Daemen, A., Turley, S.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1875PDTargeting molecular mediators of T cell exclusion for effective immunotherapy in ovarian cancer
Wang, Y, Desbois, M, Udyavar, A, Ryner, L, Kozlowski, C, Guan, Y, Dürrbaum, M, Lu, S, Fortin, J-P, Koeppen, H, Ziai, J, Chang, C-W, Lo, A, Keerthivasan, S, Plante, M, Bais, C, Hegde, P, Daemen, A, Turley, S
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
55PDIdentification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B
Das Thakur, M, Udyavar, A, Sandmann, T, Li, C, Bosch, L J W, O'Gorman, W, Li, Y, Au-Yeung, A, Takahashi, C, Bourgon, R, Daemen, A, Hegde, P, Bais, C
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Abstract P5-08-18: Biomarker (BM) results from MERiDiAN, a double-blind placebo (PLA)-controlled randomized phase 3 trial of 1st-line paclitaxel (PAC) with or without bevacizumab (BEV) for HER2-negative metastatic breast cancer (mBC)
Das Thakur, M, Bais, C, Estay, I, Vaidyanathan, R, O'Shaughnessy, J, Cameron, D, Hubeaux, S, Quah, C, Miles, D
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
BRAUER, Matthew J, GUANGLEI ZHUANG, MODRUSAN, Zora, OZAWA, Tomoko, JAMES, C. David, PHILLIPS, Heidi, HALEY, Benjamin, TAM, Rachel N. W, CLERMONT, Anne C, CHENG, Jason H, YANG, Sherry X, SWAIN, Sandra M, SCHMIDT, Maike, CHEN, Daniel, SCHERER, Stefan J, KOEPPEN, Hartmut, YEH, Ru-Fang, PENG YUE, STEPHAN, Jean-Philippe, HEGDE, Priti, FERRARA, Napoleone, SINGH, Mallika, BAIS, Carlos, YAO, Jenny, XIUMIN WU, KAMINKER, Joshua S, JURINKA, Stefanie S, KOLUMAM, Ganesh, CHUNG, Alicia S, JUBB, Adrian
Published in Clinical cancer research (01.07.2013)
Published in Clinical cancer research (01.07.2013)
Get full text
Journal Article
Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR
Bais, Carlos, Van Geelen, Albert, Eroles, Pilar, Mutlu, Agata, Chiozzini, Chiara, Dias, Sergio, Silverstein, Roy L, Rafii, Shahin, Mesri, Enrique A
Published in Cancer cell (01.02.2003)
Published in Cancer cell (01.02.2003)
Get full text
Journal Article
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
Chesi, Marta, Brents, Leslie A., Ely, Sarah A., Bais, Carlos, Robbiani, Davide F., Mesri, Enrique A., Kuehl, W. Michael, Bergsagel, P. Leif
Published in Blood (01.02.2001)
Published in Blood (01.02.2001)
Get full text
Journal Article
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
Mesri, Enrique A, Bais, Carlos, Santomasso, Bianca, Coso, Omar, Arvanitakis, Leandros, Raaka, Elizabeth Geras, Gutkind, J. Silvio, Asch, Adam S, Cesarman, Ethel, Gerhengorn, Marvin C
Published in Nature (London) (01.01.1998)
Published in Nature (London) (01.01.1998)
Get full text
Journal Article
LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL
Wick, W., Brandes, AA, Gorlia, T., Bendszus, M., Sahm, F., Taal, W., Taphoorn, M., Domont, J., Idbaih, A., Campone, M., Clement, P.M., Stupp, R., Fabbro, M., Dubois, F., Bais, C., Musmeci, D., Platten, M., Weller, M., Golfinopoulos, V., van den Bent, M.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2015)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2015)
Get full text
Journal Article
BI-22 CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Phillips, H., Sandmann, T., Li, C., Cloughesy, T., Chinot, O. L., Wick, W., Nishikawa, R., Mason, W., Henriksson, R., Saran, F., Lai, A., Moore, N., Hegde, P., Abrey, L., Bourgon, R., Garcia, J., Bais, C.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)
Get full text
Journal Article